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Abstract 
Background: Transgender and gender diverse individuals often face structural barriers to health care because of 
their gender minority status. The aim of this study was to examine the association between gender minority stress 
and access to specific health care services among transgender women and transfeminine people in China.
Methods: This multicenter cross-sectional study recruited participants between January 1st and June 30th 2020. 
Eligible participants were 18 years or older, assigned male at birth, not currently identifying as male, and living in 
China. Gender minority stress was measured using 45 items adapted from validated subscales. We examined access to 
health care services and interventions relevant to transgender and gender diverse people, including gender affirming 
interventions (hormones, surgeries), human immunodeficiency virus (HIV) and sexually transmitted infections (STIs) 
testing, pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP). Multivariable regression was used to 
measure correlations between gender minority stress and access to health care service.
Results: Three hundred and twenty-four people completed a survey and data from 277 (85.5%) people were ana-
lyzed. The mean age was 29 years old (standard deviation [SD] = 8). Participants used hormones (118/277, 42.6%), 
gender affirming surgery (26/277, 9.4%), HIV testing (220/277, 79.4%), STI testing (132/277, 47.7%), PrEP (24/276, 
8.7%), and PEP (29/267, 10.9%). Using gender affirming hormones was associated with higher levels of discrimination 
(adjusted odds ratio [aOR] 1.41, 95% confidence interval [CI] 1.17–1.70) and internalized transphobia (aOR 1.06, 95%CI 
1.00–1.12). STI testing was associated with lower levels of internalized transphobia (aOR 0.91, 95%CI 0.84–0.98).
Conclusions: Our data suggest that gender minority stress is closely related to using health services. Stigma reduc-
tion interventions and gender-affirming medical support are needed to improve transgender health.
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Background
Many transgender and gender diverse individuals have 
unmet health needs [1]. Transgender individuals have a 
high prevalence of HIV infection [2]. Despite the high 
HIV prevalence, transgender and gender diverse indi-
viduals have low uptake of HIV prevention services [3, 
4]. In addition, unmet needs for gender affirmation may 
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increase sexual health risks for some transgender popu-
lations [5]. Gender affirmation refers to the process of 
receiving recognition and support for one’s gender iden-
tity and expression, which is a key determinant of health 
and well-being for transgender and gender diverse people 
[1, 6–9]. Gender affirmation can involve medical inter-
ventions and/or changing one’s name on legal documents 
[10, 11]. Many transgender and gender diverse people 
lack access to medical gender affirmation or essential 
sexual health services. This disparity is related to stigma 
against these populations.
Stigma against transgender and gender diverse peo-
ple refers to institutional, interpersonal, and individual 
processes that systemically disadvantage them socially, 
economically, and politically [5, 12, 13]. Transgender 
and gender diverse people may experience excess stress 
because of stigma based on identifying as a gender 
minority [14]. The gender minority stress and resilience 
(GMSR) model includes stressors related to discrimina-
tion, rejection, victimization, negative expectations for 
the future, internalized transphobia, and gender identity 
concealment [15]. Minority stress places gender and sex-
ual minorities at risk for a number of negative physical 
and mental health outcomes [16, 17]. Research has sug-
gested three major pathways that stigma and discrimina-
tion impact health: psychosocial stress, access to health 
and social resources, and violence and bodily harm [18]. 
Yet, these pathways are not always independent from 
each other in contributing to health outcomes [19]. For 
example, research among sexual minority men in the US 
has suggested that psychological stress has an impact on 
their engagement in HIV prevention [19]. Understand-
ing the role of discrimination and psychological stress in 
access to sexual health prevention services is important 
because prevention is an essential part of comprehensive 
HIV control. For transgender populations in particular, 
discrimination and psychological stress can impact deci-
sions to access gender affirmation medical care when 
other gender affirmation sources are restricted, which 
has powerful implications for their well-being [6]. How-
ever, no studies have assessed these associations in low- 
and middle-income countries (LMICs), including China.
Previous data suggested that Chinese transgender and 
gender diverse people experienced high levels of dis-
crimination, victimization, and rejection [20, 21]. Cur-
rent laws and policies restrict transgender people’s access 
to gender affirming services, including gender affirming 
medical care. Transgender and gender diverse people in 
China also lack protections against employment discrim-
ination and sexual harassment [22]. Difficulties in find-
ing gender affirming medical services push many to seek 
informal interventions or self-care for gender affirmation 
(hormones and surgeries) [22]. Additionally, Chinese 
transgender and gender diverse people may be less likely 
to test for HIV or sexually transmitted infections (STIs) 
compared to cisgender HIV key populations such as men 
who have sex with men (MSM) [23]. Few studies exist 
on pre-exposure prophylaxis (PrEP) or post-exposure 
prophylaxis (PEP) uptake in this population [24–26].
The purpose of this cross-sectional study was to exam-
ine gender minority stress and access to select health care 
services among transgender women and transfeminine 
people in China, focusing on access to gender affirming 
medical services and interventions (hereafter “gender 
affirming medical care”) and sexual health services.
Methods
Study design and population
This cross-sectional study was conducted in nine cities 
across eight provinces in China. Study cities were selected 
because of their relatively large numbers of transgender 
women and transfeminine people and local community-
based organizations (CBOs) providing services to this 
population. Partnering CBOs shared study announce-
ments on social media and in-person at outreach events 
and entertainment venues (mainly night clubs). Par-
ticipants were recruited in-person before February 2020 
and then in-person and online during and after February 
2020 aligning with local regulations under the COVID-19 
pandemic. Inclusion criteria were: 18 years old or older; 
assigned male at birth; currently identify as a woman, or 
as a non-binary or gender non-conforming person; and 
typically residing in one of the study cities.
Data collection
Participants completed the survey between January 1st 
and June 30th 2020. Eligible participants completed a 
self-administered computer-assisted survey. The sur-
vey collected data on sociodemographic information, 
gender identity, gender affirming medical care use (hor-
mones, surgeries), HIV testing history, STI testing his-
tory (gonorrhea, chlamydia, syphilis, human papilloma 
virus [HPV] or condyloma acuminate, Herpes simplex 
virus 2 [HSV-2]), HIV serostatus, PrEP use, PEP use, 
gender minority stress and resilience, and sex work. We 
modified the two-step method to collect gender identity 
data [1]. Participants first selected their assigned sex at 
birth, and then gender identity from response options 
based on previous formative research and community 
expert feedback (“Transgender women”, “CD”, “Yao or 
TS”, “Women”, “Gender non-conforming, nonbinary”, and 
“other, please describe”) (unpublished). CD, TS, and Yao 
are local, reclaimed and contested identity terms [27]. 
Except for screening questions, participants were allowed 
to skip questions or choose “refuse to answer”. Partici-
pants automatically received a unique eight-digit survey 
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identification number after completing the online ques-
tionnaire (Sojump, Shanghai, China). All participants 
were required to contact CBO staff and verify ques-
tionnaire submission using their survey identification 
number to receive payment. Eligible participants who 
completed the survey received $15.
Participants who visited CBOs that routinely offered 
HIV testing services were also asked whether they would 
like to receive HIV testing. CBO staff members obtained 
informed consent and performed the test following their 
standard protocol. Results were reported in an additional 
Sojump questionnaire, as well as the location and time of 
the test, survey identification number, and consent.
We restricted eligible responses as those that took 
at least 5  min as the survey hosted over 200 questions. 
Survey completion time was used to supplement other 
measures to prevent careless responses, such as atten-
tion checks [28]. CBOs also verified each question-
naire submission using survey identification numbers 




Participants reported sociodemographic characteristics 
including age, ethnicity, housing, marital status, educa-
tion, monthly income (CNY/USD = 6.5), sexual attrac-
tion, gender identity, gender identity disclosure, whether 
they currently live as the gender they identify as, and sex 
work involvement.
Gender minority stress
We adapted the subscales from the GMSR measure to 
assess gender minority stress [15]. These subscales meas-
ured participants’ adverse experiences related to gender 
identity and perceptions about their own identity and 
transgender community. The measure includes seven 
factors: discrimination (5 items with total values ranging 
from 0 to 5, see Additional file 1: Online Appendix for a 
full list of items), rejection (6 items, 0–6), victimization (6 
items, 0–6), non-affirmation of gender identity (6 items, 
0–18), internalized transphobia (8 items, 0–24), negative 
expectation for the future (9 items, 0–27), and nondis-
closure of gender identity (5 items, 0–15). Items in the 
discrimination, rejection, and victimization subscales are 
scored 0 for “No” and 1 for “Yes”. The non-affirmation of 
gender identity, internalized transphobia, negative expec-
tation for the future, and nondisclosure of gender iden-
tity subscale items are scored on a 4-point Likert scale: 0 
(strongly disagree), 1 (somewhat disagree), 2 (somewhat 
agree), and 3 (strongly agree). All subscales were modi-
fied to omit recency and whether or not the stressors 
were experienced before age 18 to reduce participant 
burden.
The subscales were adapted to the Chinese context fol-
lowing recommendations for cross-cultural adaptation 
of self-reported measures [29]. The subscales were trans-
lated into Chinese by two graduate students with exper-
tise in public health and social science who were bilingual 
in English and Chinese, back translated into English by 
another bilingual public health graduate student, and 
reviewed by two academic and two community experts 
in transgender health in China. Ten cognitive interviews 
with transgender women and transfeminine people in 
two cities were conducted in Mandarin by a member of 
the study team (WD) and research assistants prior to 
pretesting. Feedback from the cognitive interviews were 
synthesized for each item. Scale items, instructions, and 
response options were modified based on these activi-
ties as well as prior formative and qualitative research 
(unpublished). Finally, pretesting with transgender 
women and transfeminine people was conducted prior to 
survey implementation.
Access to health care services
We included gender affirming medical care use (hor-
mones, surgeries), HIV testing, STI testing, PrEP use, and 
PEP use to examine participants’ access to health care 
services. In China, few hospitals offer gender affirming 
medical care, while HIV and STI testing can be accessed 
readily at hospitals, CBO-led testing clinics, or through 
self-testing kits purchased online. PrEP and PEP are only 
available at select infectious disease hospitals and require 
a prescription. Since PrEP was only approved in China in 
August 2020, participants in our survey likely accessed 
PrEP from informal sources or clinical trials. Similarly, 
transgender and gender diverse people in China may 
access gender affirming medical care informally due to 
low availability and high price. We did not distinguish 
between formal and informal access to these health care 
resources.
Lifetime HIV testing and PEP use were examined using 
single items with yes/no response options. STI testing in 
the past year was assessed where testing for gonorrhea, 
chlamydia, syphilis, HPV, or HSV-2 was counted as ever 
tested. For lifetime hormone intervention history, gender 
affirming surgery history, and PrEP use history, willing-
ness was assessed in addition to yes/no response options. 
In this analysis, all responses other than ever use for gen-
der affirming interventions and PrEP use were consid-
ered as never used.
Statistical analysis
Frequencies of categorical variables regarding sociode-
mographic characteristics and access to health care 
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services were calculated as the proportion of partici-
pants. Mean scores of each gender minority subscales 
were calculated. Higher scores reflected a higher degree 
of minority stress. Cases with complete responses for the 
subscale of interest were included. Missing values were 
excluded from analysis. Multivariable regression (step-
wise) was performed to assess associations between each 
gender minority stress subscale and each type of health 
care service. We adjusted for income, education, sexual 
attraction, and gender identity for analyses related to 
sexual health services access [30–33]. Additionally, we 
adjusted for whether the individual currently lives as their 
identified gender for models related to gender affirm-
ing medical care use. Adjusted odds ratios (aOR) were 
reported and the Wald 2-sided 95% confidence interval 
(CI) was used. A 2-sided P value < 0.05 was considered a 
statistically significant difference for all comparisons. All 
analyses were performed using R 3.6.3 (R Core Team).
This study was approved by institutional review boards 
at the University of North Carolina at Chapel Hill and 
Southern Medical University-Dermatology Hospital. All 
participants provided informed consent by checking a 
box on a self-administered online informed consent form 
indicating their agreement to participate in the study.
Results
Overall, 324 participants completed the survey. After 
excluding 28 submissions that were under five minutes, 
18 unverified submissions from the same IP address, and 
one response from an individual under 18 years old, we 
included 277 participants for analysis.
Sociodemographic characteristics of participants
The mean age of the participants was 29  years old 
(Table  1). Most participants were never married (89%), 
attracted to men (80.9%), and self-identified as transgen-
der women or women (58.8%). For those who identi-
fied otherwise, 37 (13.4%), 37 (13.4%), and 39 (14.1%) 
self-identified as “gender non-conforming, nonbinary”, 
“CD”, and “Yao or TS”, respectively. The majority had dis-
closed their gender identity to at least one other person 
(207/275, 75.3%), among whom most had disclosed to 
health workers (155/207, 74.9%). One hundred sixty-six 
participants (60.1%) currently live as their self-identified 
gender for most of the time. Finally, one hundred sixteen 
(42.2%) participants had ever exchanged sex for money in 
their lifetime.
Access to health care services
Table  2 presents data on participants’ access to health 
care services. For gender affirming interventions, 42.6% 
received hormone interventions while 9.4% under-
went any gender affirming surgical procedures. Most 
Table 1 Sociodemographic characteristics of transgender 
women and transfeminine people in China, December 2019–
June 2020 (N = 277)
Characteristics N (%)
Age (n = 253)* 29.04 (7.74)
Housing
 Live alone owned or rent 163 (58.8)
 Live with someone else 62 (22.4)
 Live at workplace or school 38 (13.7)
 Other 14 (5.1)
Marital status (n = 276)*
 Never married 243 (89.0)
 Engaged or married 10 (3.7)
 Separated or divorced 23 (8.4)
 Widowed 0 (0.0)
Education
 High school or below 126 (45.5)
 Some college 68 (24.5)
 College/Bachelors or above 83 (30.0)
Annual income
 No greater than USD$5538 75 (27.1)
 Greater than $5538 and no greater than $11,077 129 (46.6)
 Greater than USD$11,077 73 (26.3)
Sexual attraction
 To women 15 (5.4)
 To men and women 23 (8.3)
 To men 224 (80.9)
 To no one 3 (1.1)
 Unsure or other 12 (4.3)
Gender identity
 Transgender woman 104 (37.5)
 CD 37 (13.4)
 Yao or TS 39 (14.1)
 Women 59 (21.3)
 Gender non-conforming, nonbinary 37 (13.4)
 Other 1 (0.3)
Currently live as self-identified gender for most of the time (n = 276)*
 Yes 166 (60.1)
 No 110 (39.9)
Disclosed identity (n = 275)*
 Yes 207 (75.3)
 No 68 (24.7)
Disclosed identity to health workers
 Yes 155 (74.9)
 No 52 (25.1)
Ethnicity
 Han 217 (80.3)
 Other 53 (19.6)
Lifetime sex work involvement
 Yes 116 (42.2)
 No 159 (57.8)
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participants (79.4%) had ever received HIV testing while 
less than half (47.7%) had ever tested for STIs. For PrEP 
and PEP, 8.7% and 10.9% had ever received these inter-
ventions, respectively. The HIV prevalence among those 
ever-tested was 9.1% (20/220).
Experiences with gender minority stress
Table 3 shows the mean scores of gender minority stress 
subscales. Additional file 1 reports scores for each item. 
Participants experienced high levels of non-affirmation of 
gender identity (mean, M = 11.92) and scored the highest 
on item 2 (“I have difficulty being perceived as my gen-
der.”) (M = 2.10). Many participants (80%) also reported 
being verbally harassed or teased (victimization subscale, 
item 1).
Gender minority stress and access to health care services
Table 4 presents the associations between gender minor-
ity stress and participants’ access to health care services 
based on five different models with one model for each 
outcome. All variables included in the regression models 
are presented. Ever using hormones was associated with 
higher levels of discrimination (aOR 1.41, 95%CI 1.17–
1.70) and internalized transphobia (aOR 1.06, 95%CI 
1.00–1.12). Having undergone gender affirming surgery 
was associated with high levels of discrimination, with an 
adjusted odds ratio of 1.44 (95% CI 1.06–1.97).
HIV testing was associated with lower levels of dis-
crimination (aOR 0.70, 95%CI 0.54–0.92). STI testing was 
associated with lower levels of internalized transphobia 
(aOR 0.91, 95%CI 0.84–0.98) but higher levels of negative 
expectations for future (aOR 1.12, 95%CI 1.04–1.19). PEP 
use was associated with higher levels of stress related 
to gender identity non-disclosure (aOR 1.19, 95%CI 
1.05–1.35).
Table 1 (continued)
CD, Yao, and TS are local transfeminine identity terms
*Numbers may not add up to 277 due to missing values
Table 2 Access to health care services among transgender 
women and transfeminine people in China, December 2019–
June 2020 (N = 277)
Health care services N (%)
Hormone intervention history
 Have or currently undergoing 118 (42.6)
 Never 159 (57.4)
Gender affirming surgery
 Have or currently undergoing 26 (9.4)
 Never 251 (90.6)
HIV testing
 No 57 (20.6)
 Yes
  Lifetime HIV testing 220 (79.4)
  Lifetime facility-based HIV testing 190 (86.4)
  Lifetime HIV self-testing 150 (68.5)
STIs testing in the past year
 No 145 (52.3)
 Yes
  Gonorrhea 23 (8.3)
  Chlamydia 15 (5.4)
  Syphilis 124 (44.8)
  HPV 33 (11.9)
  HSV2 8 (2.9)
PrEP use
 Yes 24 (8.7)
 No 252 (91.3)
PEP use
 Yes 29 (10.9)
 No 238 (89.1)
Living with HIV 20 (9.1)
Table 3 Gender minority stress subscale scores among transgender women and transfeminine people, January–June 2020 (N = 277)
*Cronbach’s alpha of internal consistency based on standardized items
Subscales (number of items) Range Completion
N (%)
Alpha* Total score
Mean ±  SD¶
Discrimination (5) 0–5 273 (98.6) 0.72 2.57 ± 1.65
Rejection (6) 0–6 271 (97.8) 0.80 2.68 ± 2.08
Victimization (6) 0–6 246 (88.8) 0.84 2.64 ± 2.08
Non-affirmation of gender identity (6) 0–18 276 (99.6) 0.88 11.92 ± 3.68
Internalized transphobia (8) 0–24 274 (98.9) 0.93 12.93 ± 5.40
Negative expectations for future (9) 0–27 276 (99.6) 0.93 15.37 ± 5.70
Non-disclosure of gender identity (5) 0–15 274 (98.9) 0.89 9.15 ± 3.41
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Discussion
This study examined gender minority stress and access 
to health care resources among transgender women and 
transfeminine people in China. We identified low uptake 
of gender affirming medical care (hormones, surgeries), 
STI testing, PrEP and PEP. Discrimination and inter-
nalized transphobia are likely barriers to HIV and STI 
testing, though some gender minority stressors are also 
associated with higher uptake of some health care ser-
vices (Fig.  1). More research on gender minority stress 
and discrimination among transgender and gender 
diverse people is needed. This study contributes to our 
understanding of the role of minority stress in engaging 
health care services.
We found low STI testing rates among study par-
ticipants, which is consistent with prior studies among 
transgender women globally, including in China [23, 
34]. Our findings suggest that internalized transphobia 
is a barrier to STI—but not HIV—testing among Chi-
nese transgender women and transfeminine people. 
These results could be due to the fact that STI testing 
usually requires going to a hospital where providers 
may not be knowledgeable about transgender health 
while HIV testing is accessible at CBOs that often serve 
transgender and gender diverse people. There are ongo-
ing efforts in China to expand STI testing among other 
key populations in China, but fewer programs focused 
on transgender and gender diverse people [35, 36]. 
Table 4 Associations between gender identity stress and 
access to health care services among transgender women and 
transfeminine people in China, December 2019–June 2020
a Models were adjusted with education, income, sexual attraction, gender 
identity, and whether the individual currently live in self-identified gender for 
most of the time
b Models were adjusted with education, income, sexual attraction, and gender 
identity
Variables aOR 95% CI
Hormone intervention history (ref = never)a
 Have or currently undergoing
 Discrimination 1.41 1.17–1.70
 Internalized transphobia 1.06 1.00–1.12
Gender affirming surgery (ref = never)a
 Have or currently undergoing
 Discrimination 1.44 1.06–1.97
 Non-disclosure of gender identity 0.87 0.77–0.99
HIV testing (ref = no)b
 Discrimination 0.70 0.54–0.92
STIs testing in the past year (ref = no)b
 Internalized transphobia 0.91 0.84–0.98
 Negative expectation for future 1.12 1.04–1.19
PEP use (ref = no)b
 Non-disclosure of gender identity 1.19 1.05–1.35
Fig. 1 Gender minority stress, access to health care services, and suggested interventions based on a sample of 277 transgender women and 
transfeminine people in China, 2020
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Interventions that address or take into consideration 
internalized transphobia such as self-testing or offer-
ing testing at venues reaching transgender and gender 
diverse people (CBOs, entertainment venues), training 
healthcare providers, and establishing transgender-
friendly clinics in the vein of MSM-friendly clinics may 
increase STI testing accessibility to Chinese transgen-
der and gender diverse populations.
We found that transgender people who experienced 
discrimination and internalized transphobia were 
more likely to use gender affirming hormones. Previ-
ous data from the US suggested that these stressors 
can hinder accessing gender affirmation medical care 
[37]. This finding is aligned with the Gender Affirma-
tion Framework suggesting discrimination and inter-
nalized transphobia may cause psychological distress 
that increase need for gender affirmation [6]. For exam-
ple, those who experienced low visual conformity to 
dominant gender presentation norms are subject to 
discrimination and violence and might be more will-
ing to receive hormone intervention [13]. However, 
this was not a longitudinal study and this relationship 
between discrimination and using gender affirming 
hormones could also be explained related to partici-
pants encountering discrimination in the process of 
getting care, informal access to hormones, or internali-
zation of beauty standards. Future research is needed 
to assess the relationship between gender minority 
stress and gender affirmation services in resource-
limited settings. Research should also explore the ways 
Chinese transgender women and transfeminine peo-
ple seek gender affirmation given the low availability 
of gender affirming medical care. More gender affirm-
ing medical care and other gender affirmation services 
(e.g., easier legal process for changing gender markers 
on documents) in China are needed. Multi-level inter-
ventions, including nationwide comprehensive gender 
identity education, gender-affirming health care capac-
ity building, community empowerment and advocacy 
and psychological counseling, may also be helpful to 
reduce stress related to discrimination and internalized 
transphobia.
Similarly, the positive association between gender 
minority stressors and STI testing uptake may reflect 
that gender minority stress is closely associated with HIV 
prevention among study participants. Previous research 
on sexual minority men in the US suggested that psy-
chological distress was associated with higher levels of 
HIV prevention engagement when felt stigma was low 
[19]. Although our study did not directly measure felt 
stigma, our findings support the hypothesis that minority 
stress could mediate the relationship between stigma and 
engagement in sexual health services [38].
Research and policy implications
Our findings have research and policy implications. First, 
our study suggests the importance of gender minority 
stressors to health outcomes given the associations we 
found with healthcare service access. More research is 
needed to examine the processes that connect stigma, 
gender minority stress, and health outcomes among 
transgender and gender diverse people in China. Second, 
stigma reduction measures targeting discrimination and 
internalized transphobia would be helpful to decrease 
barriers to HIV and STI testing. Few stigma reduction 
interventions are documented in the peer-reviewed lit-
erature due to the scarcity of research on transgender 
and gender diverse people and the political sensitivity of 
this group in China. Prior efforts from community-based 
organizations in China include transgender-affirmative 
mental health practice training for clinical professionals. 
Future interventions could include online support groups 
to reduce internalized transphobia and foster resilience; 
psychological counseling interventions to address inter-
nalized transphobia; training in cultural competence for 
primary care and sexual health physicians [13, 39, 40]. 
Third, interventions should address the high levels of 
minority stress related to accessing health services and 
interventions. Increasing the quality of gender affirming 
medical care, establishing standard operating protocols 
for medical professionals, and removing barriers to these 
services are important next steps. In terms of stressors 
associated with sexual health care access, we suggest 
integrating mental health services with sexual health 
interventions and care [41–43]. Sexual health services 
could integrate mental health components by directly 
providing counseling services, providing referrals to psy-
chological services, and organizing community engage-
ment activities for the transgender and gender diverse 
people [42, 44, 45].
Limitations
Our study should be read with limitations. First, this 
cross-sectional study is unable to establish temporal-
ity or explain associations. Additional research (longi-
tudinal and qualitative) is needed on transgender and 
gender diverse people’s experiences of health care ser-
vice access in order to reduce minority stress. Second, 
most of the partnering community-based organiza-
tions were groups providing HIV testing services, as 
there were no transgender-specific CBOs that we knew 
of in most study cities. Collaborating organizations pro-
moted the study through social media platforms and 
in-person outreach. This recruitment process could 
introduce selection bias. Compared to samples col-
lected in previous studies [20, 25], our participants have 
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similar sociodemographic characteristics with regards to 
age, education, and income. However, due to the overall 
marginalization of transgender and gender diverse peo-
ple in China, people who were older, less familiar with 
online survey, or less engaged in community-based HIV 
services may have been undersampled. A prior study 
in China [27] has demonstrated that it is feasible to use 
methods such as respondent-driven sampling to recruit 
participants. Building long-term, respectful partnerships 
with community-based organizations is key to reaching 
diverse participants across China. Third, our survey did 
not distinguish between informal and formal access to 
healthcare services such as hormone interventions. It is 
likely that differing gender minority stressors are relevant 
depending on access channels.
Conclusions
Gender minority stress is correlated with transgen-
der gender diverse people’s access to health care ser-
vices in different ways. Discrimination and internalized 
transphobia are barriers to HIV and STI testing, while 
some gender minority stressors are associated with 
higher engagement in gender affirming medical care 
and sexual health prevention services. Future research 
in China should investigate the pathways that connect 
stigma, minority stress, and health outcomes to better 
understand transgender health inequalities and to inform 
interventions. Future policy is needed to prioritize pro-
viding gender-affirming medical services for Chinese 
transgender individuals and include mental health ser-
vices in transgender health care delivery.
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